Aviva PLC Dexcom Inc Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Dexcom Inc stock. As of the latest transaction made, Aviva PLC holds 177,280 shares of DXCM stock, worth $12.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

177,280

Previous 172,875 2.55%

Holding current value

$12.9 Million

Previous $19.6 Million 39.38%

% of portfolio

0.03%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $281,920 - $511,244	4,405 Added 2.55%	177,280 $11.9 Million
Q2 2024 Aug 02, 2024	BUY	$110.31 - $140.45 $4.7 Million - $5.99 Million	42,620 Added 32.72%	172,875 $19.6 Million
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $3.82 Million - $4.68 Million	33,423 Added 34.52%	130,255 $18.1 Million
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $10.6 Million - $17.5 Million	-140,565 Reduced 59.21%	96,832 $12 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $2.88 Million - $4.61 Million	33,441 Added 16.4%	237,397 $22.1 Million
Q2 2023 Aug 10, 2023	BUY	$112.47 - $130.98 $10.8 Million - $12.6 Million	96,413 Added 89.65%	203,956 $26.2 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $3.87 Million - $4.58 Million	-37,230 Reduced 25.72%	107,543 $12.5 Million
Q4 2022 Feb 09, 2023	SELL	$84.98 - $122.67 $10.2 Million - $14.8 Million	-120,374 Reduced 45.4%	144,773 $16.4 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $2.02 Million - $2.49 Million	-26,403 Reduced 9.06%	265,147 $21.4 Million
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $16.5 Million - $32.3 Million	242,765 Added 497.62%	291,550 $21.7 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $1.68 Million - $2.32 Million	17,816 Added 57.53%	48,785 $25 Million
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $37,922 - $47,543	-292 Reduced 0.93%	30,969 $16.6 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $130,399 - $174,965	-1,222 Reduced 3.76%	31,261 $17.1 Million
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $133,066 - $177,328	1,643 Added 5.33%	32,483 $13.9 Million
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $14,668 - $18,120	-173 Reduced 0.56%	30,840 $11.1 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $102,648 - $137,522	1,316 Added 4.43%	31,013 $11.5 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $86,436 - $102,219	-905 Reduced 2.96%	29,697 $12.2 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $926,410 - $1.56 Million	-14,780 Reduced 32.57%	30,602 $12.4 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $648,940 - $1.03 Million	13,579 Added 42.7%	45,382 $12.2 Million
Q4 2019 Feb 10, 2020	SELL	$36.62 - $57.29 $1,684 - $2,635	-46 Reduced 0.14%	31,803 $6.96 Million
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $14,709 - $18,133	-414 Reduced 1.28%	31,849 $4.75 Million
Q2 2019 Jul 30, 2019	SELL	$27.84 - $38.92 $19,738 - $27,594	-709 Reduced 2.15%	32,263 $4.83 Million
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $925,524 - $1.26 Million	32,972 New	32,972 $3.93 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account